20/20 GeneSystems
20/20 GeneSystems's Overview
20/20 GeneSystems, Inc. is a digital diagnostics company committed to reducing cancer mortality through innovative, AI-powered blood tests for early cancer detection. Their primary focus is on developing and commercializing multi-cancer screening tests from a single blood draw, such as their flagship product, OneTest™. By leveraging machine learning algorithms and a panel of tumor-associated biomarkers, 20/20 GeneSystems aims to provide clinicians and patients with actionable insights for detecting cancers at their earliest, most treatable stages. Their work addresses a critical need for more accessible, accurate, and less invasive cancer screening methods to improve patient outcomes and save lives.
Where is 20/20 GeneSystems's Headquarters?
HQ Function
The headquarters serves as the central hub for research and development, clinical laboratory operations (CLIA-certified), corporate administration, and strategic business development.
Notable Features:
The facility includes state-of-the-art laboratory space equipped for molecular diagnostics and biomarker analysis, located in a prominent biotech corridor.
Work Culture:
The work culture at 20/20 GeneSystems is likely mission-driven, fostering innovation, collaboration among scientists and business professionals, and a strong focus on scientific rigor and patient impact. Employees are dedicated to advancing cancer diagnostics.
HQ Significance:
Its location in Rockville, MD, places it in close proximity to key federal health institutions like the NIH and FDA, as well as a rich ecosystem of biotech companies and research talent, fostering collaboration and innovation.
Values Reflected in HQ: The headquarters reflects values of innovation, precision in diagnostics, scientific excellence, and a commitment to improving public health through early cancer detection.
Location:
While 20/20 GeneSystems is headquartered and primarily operates within the United States, particularly with its CLIA-certified lab in Maryland, its vision and the applicability of its diagnostic tests are global. The company actively seeks partnerships and collaborations that could extend the reach of its cancer screening technologies to international markets. This includes engaging with international distributors, healthcare systems, and participating in global oncology conferences to share research and explore opportunities for making their tests available worldwide. Their tests, such as OneTest™, are designed to address a global health challenge.
Street Address:
9430 Key West Ave
City:
Rockville
State/Province:
MD
Country:
USA
20/20 GeneSystems's Global Presence
San Antonio, TX, USA
Address: Undisclosed specific address for commercial operations/partnerships (Note: Primary operations are in Rockville, MD. This is a representative example for a potential secondary site for specific functions like sales or clinical trial coordination if not solely remote)
To expand market reach, facilitate clinical collaborations, and support sales and distribution efforts in key regional markets. (This is a speculative entry as clear public information on distinct secondary offices is limited; the company is primarily centered in Rockville).
Buying Intent Signals for 20/20 GeneSystems
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of 20/20 GeneSystems
As of April 2025, 20/20 GeneSystems' leadership includes:
Investors of 20/20 GeneSystems
20/20 GeneSystems has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year, 20/20 GeneSystems has continued to build its team to support its growth and product development. Public announcements of specific C-suite level hires or exits are not frequent for a company of this size unless strategically significant. Focus appears to be on scientific and operational team expansion rather than major top-level executive turnover.
Technology (Tech Stack) used by 20/20 GeneSystems
Discover the tools 20/20 GeneSystems uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
20/20 GeneSystems Email Formats and Examples
20/20 GeneSystems likely uses standard corporate email formats. Based on common patterns for companies of this size and industry, the most probable format is the first initial followed by the last name.
[first_initial][last]@2020genesystems.com
Format
jcohen@2020genesystems.com
Example
80%
Success rate
News and media
20/20 GeneSystems • June 27, 2023
20/20 GeneSystems’ OneTest™-Prostate Now Available in All 50 States
20/20 GeneSystems announced that its AI-powered blood test, OneTest™-Prostate, is now available to patients and physicians in all 50 U.S. states. This expansion significantly increases access to this innovative tool for early prostate cancer detection....more
GlobeNewswire • April 5, 2022
20/20 GeneSystems Receives CLIA Certification for its Maryland Laboratory
20/20 GeneSystems announced that its clinical laboratory in Rockville, Maryland has received Clinical Laboratory Improvement Amendments (CLIA) certification from the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Services (CMS). This certification allows the company to perform its proprietary laboratory-developed tests (LDTs), including OneTest for cancer....more
BioBuzz • October 13, 2021
20/20 GeneSystems Expands its Executive Team as its Multi-Cancer Screening Test Gains Traction
20/20 GeneSystems announced additions to its executive team, including naming Harvey P. Hason as Chief Financial Officer and Dr. L. Darlene Pray as Vice President, Clinical and Regulatory Affairs, to support the company's growth and commercialization of its OneTest multi-cancer screening blood test....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including 20/20 GeneSystems, are just a search away.